[The oral administration of vitamin-A-acid in leukoplakias, hyperkeratoses and squamous cell carcinomas: results and tolerance].
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002338:Carotenoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004890:Erythema / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D007972:Leukoplakia, Oral / Q000188:drug therapy*; D008047:Lip Diseases / Q000139:chemically induced; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*
D002338:Carotenoids
Die perorale Anwendung von Vitamin-A-Säure bei Leukoplakien, Hyperkeratosen und Plattenepithelkarzinomen: Ergebnisse und Verträglichkeit.